Your browser doesn't support javascript.
loading
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.
Garancher, Alexandra; Suzuki, Hiromichi; Haricharan, Svasti; Chau, Lianne Q; Masihi, Meher Beigi; Rusert, Jessica M; Norris, Paula S; Carrette, Florent; Romero, Megan M; Morrissy, Sorana A; Skowron, Patryk; Cavalli, Florence M G; Farooq, Hamza; Ramaswamy, Vijay; Jones, Steven J M; Moore, Richard A; Mungall, Andrew J; Ma, Yussanne; Thiessen, Nina; Li, Yisu; Morcavallo, Alaide; Qi, Lin; Kogiso, Mari; Du, Yuchen; Baxter, Patricia; Henderson, Jacob J; Crawford, John R; Levy, Michael L; Olson, James M; Cho, Yoon-Jae; Deshpande, Aniruddha J; Li, Xiao-Nan; Chesler, Louis; Marra, Marco A; Wajant, Harald; Becher, Oren J; Bradley, Linda M; Ware, Carl F; Taylor, Michael D; Wechsler-Reya, Robert J.
Afiliación
  • Garancher A; Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Suzuki H; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
  • Haricharan S; Tumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Chau LQ; Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Masihi MB; Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Rusert JM; Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Norris PS; Tumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Carrette F; Tumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Romero MM; Department of Pediatrics, Northwestern University, Chicago, IL, USA.
  • Morrissy SA; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
  • Skowron P; Dept. of Biochemistry and Molecular Biology, Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
  • Cavalli FMG; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
  • Farooq H; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
  • Ramaswamy V; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
  • Jones SJM; Division of Haematology/Oncology and Department of Paediatrics, Hospital for Sick Children, Toronto, Canada.
  • Moore RA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Ma Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Thiessen N; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Li Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Morcavallo A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Qi L; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Kogiso M; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Du Y; Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, IL, USA.
  • Baxter P; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Henderson JJ; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Crawford JR; Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, IL, USA.
  • Levy ML; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Olson JM; Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
  • Cho YJ; Departments of Pediatrics and Neurosciences, University of California, San Diego - Rady Children's Hospital, San Diego, CA, USA.
  • Deshpande AJ; Department of Neurosurgery, University of California San Diego - Rady Children's Hospital, San Diego, CA, USA.
  • Li XN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chesler L; Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
  • Marra MA; Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Wajant H; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Becher OJ; Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, IL, USA.
  • Bradley LM; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
  • Ware CF; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
  • Taylor MD; Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Wechsler-Reya RJ; Department of Pediatrics, Northwestern University, Chicago, IL, USA.
Nat Neurosci ; 25(1): 127, 2022 01.
Article en En | MEDLINE | ID: mdl-34907396
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos